GovBidPulseFormDPulseAccessPulseCitePulseLocalSchemaPulseIntelligence feedsSupport

TCM Life Science Inc. raised $16,666 (Newark, DE)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 09:16:10 GMT

TCM Life Science Inc. plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

63 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $333 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $16,666 so far: a smaller raise.
  • Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
  • New filing (not an amendment): the raise is fresh.
  • Incorporated in the last five years: likely still building out finance and insurance.
FieldValue
IndustryBiotechnology (Healthcare & Life Sciences)
Operating companyYes
Exemption506(b)
Amount sold$16,666
Total offeringIndefinite / n/a
Investors so far2
First sale2026-10-12
Filed2026-10-26
EntityCorporation, incorporated 2026

Executives and related persons (from the filing)

  • Ya-Chun Wang: Executive Officer, Director
  • Huan-Chin Hsu: Director

View the filing on SEC EDGAR

Markdown version

TCM Life Science Inc. vs. top 3 peers

OrganizationLocationCapital raisedRecord date
TCM Life Science Inc.Newark$16,6662026-10-26
ChemoMouthpiece, LLCWilmington$400,0002026-10-30
Tru Singular Health, Inc.Natick$1,000,0002026-10-30
Swep Bio, Inc.Scarsdale$2,499,9892026-10-29

Related records

Newly funded companies in Delaware (SEC Form D) Newly funded Healthcare & Life Sciences companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.